Jazz Pharmaceuticals (JAZZ) Beats Q4 Earnings and Revenue Estimates

Jazz Pharmaceuticals (JAZZ) came out with quarterly earnings of $6.64 per share, beating the Zacks Consensus Estimate of $6.62 per share. This compares to earnings of $6.6 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +0.27%. A quarter ago, it was expected that this drugmaker would post earnings of $5.74 per share when it actually produced earnings of $8.13, delivering a surprise of +41.64%.Over the last four quarters, the c ...